The never-ending struggle with laboratory testing for Clostridium difficile infection

Journal of Comparative Effectiveness Research

Volumn 5, Issue 2, 2016, Pages 113-116

  Polage, Christopher R ^a   Turkiewicz, Joanna V ^a   Cohen, Stuart H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clostridium difficile; diagnostic testing; diarrhea; healthcare associated infection; outcomes

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; EDITORIAL; ENTEROCOLITIS; GASTROINTESTINAL INFECTION; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; LABORATORY TEST; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TOXIN ANALYSIS; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HOSPITAL LABORATORY; ISOLATION AND PURIFICATION;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HUMANS; LABORATORIES, HOSPITAL;

EID: 84961825655     PISSN: 20426305     EISSN: 20426313     Source Type: Journal    
DOI: 10.2217/cer-2016-0001     Document Type: Editorial

References (20)

1. Barbut F, Fitzpatrick F, Kuijper EJ et al. Clostridium difficile infection in Europe-A CDI Europe Report. www.multivu.com
2. Lessa FC, Mu Y, Bamberg WM et al. Burden of Clostridium difficile infection in the United States. N. Engl. J.Med. 372(9), 825-834 (2015).
3. Levy AR, Szabo SM, Lozano-Ortega G et al. Incidence and costs of Clostridium difficile infections in Canada. Open Forum Infect. Dis. 2(3), ofv076 (2015).
4. Freeman J, Bauer MP, Baines SD et al. The changing epidemiology of Clostridium difficile infections. Clin. Microbiol. Rev. 23(3), 529-549 (2010).
5. Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infections. Clin. Infect. Dis. 16(Suppl. 4), S439-S442 (1993).
6. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 298(10), 531-534 (1978).
7. Bartlett JG, Chang TW, Onderdonk AB. Will the real Clostridium species responsible for antibiotic-associated colitis please step forward? Lancet 1(8059), 338 (1978).
8. Bartlett JG, Taylor NS, Chang T, Dzink J. Clinical and laboratory observations in Clostridium difficile colitis. Am. J. Clin. Nutr. 33(Suppl. 11), 2521-2526 (1980).
9. Gerding DN, Olson MM, Peterson LR et al. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch. Intern. Med. 146(1), 95-100 (1986).
10. Dallal RM, Harbrecht BG, Boujoukas AJ et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann. Surg. 235(3), 363-372 (2002).
11. Pepin J, Valiquette L, Alary ME et al. Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171(5), 466-472 (2004).
12. Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31(5), 431-455 (2010).
13. Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin. Microbiol. Rev. 26(3), 604-630 (2013).
14. Longtin Y, Trottier S, Brochu G et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin. Infect. Dis. 56(1), 67-73 (2013).
15. Polage CR, Chin DL, Leslie JL, Tang J, Cohen SH, Solnick JV. Outcomes in patients tested for Clostridium difficile toxins. Diagn. Microbiol. Infect. Dis. 74(4), 369-373 (2012).
16. Planche TD, Davies KA, Coen PG et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect. Dis. 13(11), 936-945 (2013).
17. Polage CR, Gyorke CE, Kennedy MA et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern. Med. 175(11), 1792-1801 (2015).
18. Guerrero DM, Chou C, Jury LA, Nerandzic MM, Cadnum JC, Donskey CJ. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. Clin. Infect. Dis. 53(3), 287-290 (2011).
19. Humphries RM, Uslan DZ, Rubin Z. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity. J. Clin. Microbiol. 51(3), 869-873 (2013).
20. Berry N, Sewell B, Jafri S et al. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection. J. Hosp. Infect. 87(2), 109-114 (2014).